You are here

Medicare

Biden's Medicare drug price negotiations will leave pharma mostly unscathed: CBO

Fierce Pharma

Sat, 11/20/21 - 11:55 am

pharma industry

Build Back Better

Democrats’ major drug pricing reforms clear a hurdle in the House

Stat

Fri, 11/19/21 - 10:53 am

MCIT breakthrough device payment pathway included in Cures 2.0 bill

Medtech Dive

Thu, 11/18/21 - 10:42 am

breakthrough device

EU steers clear of Aduhelm as a bigger headache threatens

EP Vantage

Thu, 11/18/21 - 10:33 am

Alzheimer's disease

Anticipating Aduhelm's costs, Medicare plans big jump in premiums

BioPharma Dive

Mon, 11/15/21 - 12:42 pm

Alzheimer's disease

CMS scraps coverage rule for breakthrough devices

MedCity News

Sun, 11/14/21 - 10:46 pm

breakthrough device

Mixed court decisions for Novartis in DC and Sanofi, Novo Nordisk in NJ further complicate whose interpretation of 340B is correct

Endpoints

Mon, 11/8/21 - 10:46 am

Democrats' drug pricing deal is 'not a bad outcome' for pharma, analysts write

Fierce Pharma

Fri, 11/5/21 - 12:50 pm

CMS reinstates Medicare's inpatient-only list in final rule, reversing Trump-era nix

Medtech Dive

Thu, 11/4/21 - 10:29 am

inpatient procedures

Dems close in on Medicare prescription drug negotiation compromise

Politico

Tue, 11/2/21 - 10:56 am

White House kills off major drug pricing reforms as Democrats fail to coalesce around Medicare negotiation plan

Endpoints

Thu, 10/28/21 - 10:46 am

Why Humana Is Suing Biogen

Motley Fool

Sat, 10/9/21 - 11:04 pm

Pfizer prohibited from subsidizing its heart drugs for Medicare patients

Beckers Hospital Review

Mon, 10/4/21 - 11:12 pm

Pfizer loses lawsuit over U.S. limits on drug copay assistance

Reuters

Sun, 10/3/21 - 08:07 pm

copay asssistance programs

anti-kickback statute

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington's intensifying drug-pricing push

Fierce Pharma

Thu, 09/16/21 - 10:50 am

Bristol Myers Squibb

House moderates rebel against Pelosi drug pricing plan, leaving bill’s fate uncertain

Stat

Tue, 09/14/21 - 10:37 pm

CMS moves to scrap MCIT rule due to clinical evidence concerns

Medtech Dive

Tue, 09/14/21 - 10:56 am

breakthrough device

Court denies Teva's motion to dismiss Copaxone kickbacks case

Globes, Israel

Mon, 09/13/21 - 11:33 pm

Teva Pharmaceutical

False Claims Act

New Biden plan to lower drug prices drawn from familiar Democratic playbook

Stat

Thu, 09/9/21 - 11:21 pm

With drug pricing reform potentially closer than ever, Public Citizen pens new letter calling for change

Endpoints

Wed, 09/1/21 - 11:08 am

Pages